FIELD: biotechnology.
SUBSTANCE: disclosed is use of fermented milk products fermented with probiotic strains of bacteria Bacillus subtilis TNP-3 and Bacillus subtilis TNP-5, in treating patients with pulmonary tuberculosis with a standard long-term anti-tuberculosis therapy taking into account the drug resistance of mycobacterium tuberculosis as an additional food in addition to stationary food once a day at noon.
EFFECT: invention provides higher tolerance and effectiveness of anti-tuberculosis therapy, reduced frequency of undesirable adverse reactions from anti-tuberculosis drugs.
1 cl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING PATIENTS SUFFERING PULMONARY TUBERCULOSIS | 2011 |
|
RU2456006C1 |
| METHOD FOR COMPLEX SEQUENTIAL USE OF PATHOGENETIC AGENTS IN TREATMENT IN CHILDREN WITH TUBERCULOSIS INFECTION | 2020 |
|
RU2746642C1 |
| METHOD FOR SUPPRESSING VIABILITY OF PATHOGENIC LEPTOSPIRA | 2013 |
|
RU2537271C1 |
| METABIOTIC COMPOSITION BASED ON METABOLITES OF BACILLUS SUBTILIS | 2022 |
|
RU2803259C1 |
| METHOD FOR SANATION OF COWS UDDER WITH APPLICATION OF BACILLUS SUBTILIS BACTERIA STRAINS | 2018 |
|
RU2694204C1 |
| Bacillus subtiliS STRAIN CAPABLE OF SPLITTING SUGARS AND HAVING ANTAGONISTIC EFFECT ON PATHOGENIC AND OPPORTUNISTIC PATHOGENIC BACTERIA AND FUNGI, AND USE THEREOF | 2013 |
|
RU2539762C1 |
| METHOD OF TREATING INTESTINAL DYSBACTERIOSIS | 2015 |
|
RU2602696C1 |
| TUBERCULOSIS TREATMENT METHOD | 2002 |
|
RU2219939C1 |
| METABIOTIC COMPOSITION TO ENSURE COLONISATION RESISTANCE OF HUMAN INTESTINAL MICROBIOCENOSIS | 2015 |
|
RU2589818C1 |
| BIOLOGICAL PREPARATION BALIS FOR PREVENTING AND TREATING INFECTIOUS DISEASES | 2010 |
|
RU2454238C1 |
